CURIS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
CURIS, INC. (CRIS) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 2.14 million shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2023-03-13
- CURIS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2020-06-30 was 110.00K shares, a 26.67% decline year-over-year.
- CURIS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2020-03-31 was 140.00K shares, a 366.67% increase year-over-year.
- CURIS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2019-12-31 was 157.50K shares.
- CURIS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2019-09-30 was 238.00K shares.
- CURIS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2022 was 2.14M shares, a 197.27% increase from fiscal 2021.
- CURIS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2021 was 720.20K shares, a 188.08% increase from fiscal 2020.
- CURIS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2020 was 250.00K shares, a 56.56% decline from fiscal 2019.
- CURIS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2019 was 575.50K shares, a 525.54% increase from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|---|---|---|
| 2022-12-31 | 2.14M shares 10-K · filed 2023-03-13 | |||
| 2021-12-31 | 720.20K shares 10-K · filed 2022-02-24 | |||
| 2020-12-31 | 250.00K shares 10-K · filed 2021-03-16 | |||
| 2020-06-30 | 110.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 250.00K shares 10-Q · filed 2020-08-04 | 407.50K shares derived: sum of 3 quarters · filed 2020-08-04 | 645.50K shares derived: sum of 4 quarters · filed 2020-08-04 |
| 2020-03-31 | 140.00K shares 10-Q · filed 2020-05-12 | 297.50K shares derived: sum of 2 quarters · filed 2020-05-12 | 535.50K shares derived: sum of 3 quarters · filed 2020-05-12 | 685.50K shares derived: sum of 4 quarters · filed 2020-05-12 |
| 2019-12-31 | 157.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | 395.50K shares derived: sum of 2 quarters · filed 2020-03-19 | 545.50K shares derived: sum of 3 quarters · filed 2020-03-19 | 575.50K shares 10-K · filed 2020-03-19 |
| 2019-09-30 | 238.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 388.00K shares derived: sum of 2 quarters · filed 2019-11-05 | 418.00K shares 10-Q · filed 2019-11-05 | |
| 2019-06-30 | 150.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 180.00K shares 10-Q · filed 2019-08-09 | ||
| 2019-03-31 | 30.00K shares 10-Q · filed 2019-05-14 | |||
| 2018-12-31 | 92.00K shares 10-K · filed 2019-03-26 | |||
| 2017-12-31 | 644.00K shares 10-K · filed 2018-03-08 | |||
| 2016-12-31 | 2.45M shares 10-K · filed 2017-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |